| Wang, Fu-Sheng |
NCT05085145: Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV |
|
|
| Recruiting | 4 | 200 | RoW | Coronavirus vaccine | Beijing 302 Hospital | People Living With HIV, COVID-19, Vaccine | 09/22 | 09/22 | | |
NCT06503796: Antiviral Therapy in Infants With HBV Infection |
|
|
| Not yet recruiting | 4 | 60 | RoW | Lamivudine, Interferon | Beijing 302 Hospital | HBV | 11/25 | 11/26 | | |
NCT03945487: Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis |
|
|
| Recruiting | 2 | 200 | RoW | umbilical cord-derived mesenchymal stem cell, Comprehensive treatment | Beijing 302 Hospital | Decompensated Liver Cirrhosis | 12/21 | 12/23 | | |
NCT05121870: Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis |
|
|
| Recruiting | 2 | 240 | RoW | UC-MSCs, Saline containing 1% Human serum albumin（solution without UC-MSCs） | Beijing 302 Hospital, Shanghai Changzheng Hospital, LanZhou University, Renmin Hospital of Wuhan University, Chinese PLA General Hospital, VCANBIO CELL & GENE ENGINEERING CORP.,LTD, China | Decompensated Cirrhosis | 06/23 | 12/23 | | |
NCT04098770: Allogeneic Adoptive Immune Therapy for Advanced AIDS Patients |
|
|
| Recruiting | 2 | 240 | RoW | Allogeneic Adoptive Immune Therapy | Beijing 302 Hospital, The 6th people's Hospital of Xinjiang province, The 4th people's hospital of Nanning City, The 3th people's hospital of Shenzhen City, Shanghai Public Health Clinical Center, Yunnan Provincial Hospital of Infectious Diseases | AIDS Patients | 12/23 | 12/24 | | |
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) |
|
|
| Recruiting | 2 | 140 | RoW | UC-MSCs, Placebo(solution without UC-MSCs) | Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital | Decompensated Cirrhosis | 06/25 | 06/27 | | |
NCT04162158: Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma |
|
|
| Recruiting | 1/2 | 200 | RoW | allogeneic NK cells therapy | Beijing 302 Hospital, Shenzhen Third People's Hospital, The first People's Hospital of Zhengzhou | Hepatocellular Carcinoma | 10/22 | 10/24 | | |
NCT05273541: Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer |
|
|
| Recruiting | 1/2 | 100 | RoW | Coronavirus vaccination | Beijing 302 Hospital | Patients With Cancer, Vaccine Reaction, COVID-19 | 12/22 | 07/23 | | |
| Recruiting | 1/2 | 80 | RoW | mesenchymal stem cells, KY-2023-2-6-2, saline | Cell Energy Life Sciences Group Co. LTD, Beijing 302 Hospital | Lung Injury | 05/26 | 05/26 | | |
NCT06463522: Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma |
|
|
| Recruiting | 1/2 | 20 | RoW | Autologous Tumor-infiltrating Lymphocytes | Beijing 302 Hospital | Hepatocellular Carcinoma | 07/25 | 07/26 | | |
NCT05939167: Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage |
|
|
| Recruiting | 1/2 | 150 | RoW | mesenchymal stem cell, umbilical cord derived MSCs, saline | Cell Energy Life Sciences Group Co. LTD, Beijing 302 Hospital, Shenzhen Third People's Hospital, Fifth Hospital of Shijiazhuang City, Beijing YouAn Hospital | AIDS | 07/25 | 07/26 | | |
NCT04518774: Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial |
|
|
| Recruiting | 1 | 8 | RoW | Ex-vivo expanded allogeneic γδT cells | Beijing 302 Hospital, Chinese Academy of Medical Sciences, Beijing GD Initiative Cell Therapy Technology Co., Ltd. | Hepatocellular Carcinoma | 06/21 | 08/21 | | |
| Not yet recruiting | 1 | 8 | RoW | CAR-T cells, HIV-1 specific chimeric antigen receptor T cells | Beijing 302 Hospital, Tsinghua University | HIV-1 | 06/22 | 10/22 | | |
NCT05227846: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1) |
|
|
| Recruiting | 1 | 12 | RoW | Human Umbilical Cord-derived Mesenchymal Stem Cells | Beijing 302 Hospital, VCANBIO Cell & Gene Engineering Corporation, Ltd | Decompensated Cirrhosis | 06/24 | 03/25 | | |
NCT05984303: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b) |
|
|
| Not yet recruiting | 1 | 6 | RoW | Human Umbilical Cord-derived Mesenchymal Stem Cells | Beijing 302 Hospital, Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China | Decompensated Cirrhosis | 08/24 | 08/25 | | |
NCT05905731: Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B |
|
|
| Active, not recruiting | 1 | 20 | RoW | TCR-T | Beijing 302 Hospital | Chronic Hepatitis B | 06/25 | 06/26 | | |
NCT05018078: Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer |
|
|
| Recruiting | N/A | 300 | RoW | Coronavirus vaccine | Beijing 302 Hospital | Patients With Cancers, COVID-19, Vaccine | 08/23 | 10/23 | | |
| Recruiting | N/A | 50 | RoW | Sintilimab, NAs, ETV/TDF/TAF, Peg-IFNα-2b | Beijing 302 Hospital | Chronic Hepatitis B | 12/25 | 12/25 | | |
NCT05017805: COVID-19 Vaccines in Patients With Chronic Liver Disease |
|
|
| Recruiting | N/A | 300 | RoW | COVID-19 Vaccines | Beijing 302 Hospital | Liver Disease Chronic | 08/24 | 08/25 | | |
NCT05140837: Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106) |
|
|
| Recruiting | N/A | 10000 | RoW | Psychometric hepatic encephalopathy score & Stroop test, Drug therapy | Hepatopancreatobiliary Surgery Institute of Gansu Province, The First Affiliated Hospital of Anhui Medical University, Beijing Ditan Hospital, Chongqing Public Health Medical Treatment Center, Meng Chao Hepatobiliary Hospital of Fujian Medical University, Guangxi Zhuang Autonomous Region People's Hospital, Shenzhen Third People's Hospital, Guizhou people's Hospital, Wuhan Union Hospital, China, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Hainan Medical University, The Third Affiliated Hospital of Hebei Medical University, The Second Affiliated Hospital of Harbin Medical University, Henan Provincial People's Hospital, Ganzhou Fifth People's Hospital, The First Hospital of Jilin University, Jiangsu People's Hospital, First Hospital of China Medical University, The Second Affiliated Hospital of Baotou Medical College, Ningxia Medical University General Hospital, The Fourth People's Hospital of Qinghai Province, Xi'an High-tech Hospital, The 10th People's Hospital affiliated to Tongji University, Qilu Hospital of Shandong University, The Third People's Hospital of Taiyuan, Xichang People's Hospital, Tianjin Third Central Hospital, The Third People's Hospital of Tibet Autonomous Region, Xinjiang Autonomous Region People's Hospital, Second People's Hospital of Yunnan Province, Hangzhou Xixi hospital, LanZhou University | Hepatic Encephalopathy, Cirrhosis | 12/24 | 12/24 | | |
| Shi, Lei |
NCT05121870: Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis |
|
|
| Recruiting | 2 | 240 | RoW | UC-MSCs, Saline containing 1% Human serum albumin（solution without UC-MSCs） | Beijing 302 Hospital, Shanghai Changzheng Hospital, LanZhou University, Renmin Hospital of Wuhan University, Chinese PLA General Hospital, VCANBIO CELL & GENE ENGINEERING CORP.,LTD, China | Decompensated Cirrhosis | 06/23 | 12/23 | | |
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) |
|
|
| Recruiting | 2 | 140 | RoW | UC-MSCs, Placebo(solution without UC-MSCs) | Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital | Decompensated Cirrhosis | 06/25 | 06/27 | | |
NCT05227846: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1) |
|
|
| Recruiting | 1 | 12 | RoW | Human Umbilical Cord-derived Mesenchymal Stem Cells | Beijing 302 Hospital, VCANBIO Cell & Gene Engineering Corporation, Ltd | Decompensated Cirrhosis | 06/24 | 03/25 | | |
NCT05984303: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b) |
|
|
| Not yet recruiting | 1 | 6 | RoW | Human Umbilical Cord-derived Mesenchymal Stem Cells | Beijing 302 Hospital, Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China | Decompensated Cirrhosis | 08/24 | 08/25 | | |
NCT04167982: Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris |
|
|
| Recruiting | N/A | 234 | RoW | Aminolevulinic acid photodynamic therapy, Oral conventional-dose isotretinoin, Oral low-dose isotretinoin | Shanghai Dermatology Hospital, Huadong Hospital, RenJi Hospital | Acne | 11/22 | 11/22 | | |
